Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Global Medtech Guidance Tracker: April 2021

Executive Summary

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-two guidance documents have been posted on the tracker since its last update.

You may also be interested in...



Singapore’s Medtech Thought Leader Role And ASEAN Update

Singapore drives much of the medtech regulatory and policy thought leadership in the ASEAN region, as shown in its regulatory collaboration with Thailand and actions on cybersecurity and packaging waste.

Latest EU Clinical investigation Guidance Considers ‘Substantial Modification’ Definition

In some cases, a “substantial” change to a clinical investigation will mean having to start anew. Industry is in urgent need of clarification of the term. But does latest EU guidance help sufficiently?

US Survey Shows Pharma More Open To Remote Patient Monitoring

COVID-19 is driving changes to how clinical trials are being conducted in the US, with 44% of respondents who participated in a recent survey saying they have adapted or plan to become decentralized in coming months.

Topics

UsernamePublicRestriction

Register

MT143988

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel